Since identification of EZH2 in the research of protooncogene product Vav [3], studies have shown that EZH2 is highly expressed in tumorigenesis, which regulates the expression of tumor suppressor genes, such as in breast cancer, prostate cancer, and lung cancer [4–6]. This evidence concerns the gene EZH2 and lung carcinoma.